The invention relates to compounds of formula (I): where A is an optionally substituted heteroaryl, useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods
-
Page/Page column 29
(2010/02/17)
More Articles about upstream products of 1205602-91-0